Vertex: The Quiet Biotech Compounder I'd Happily Hold Through Any Market CrashThe Motley Fool • 02/18/26
Vertex to Participate in TD Cowen 46th Annual Health Care Conference on March 3Business Wire • 02/17/26
VRTX's Q4 Earnings Miss Mark, Revenues Beat on Higher Product SalesZacks Investment Research • 02/13/26
Vertex (VRTX) Q4 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 02/13/26
Vertex Pharma forecasts 2026 revenue in-line, expects growth in cystic fibrosis treatmentsReuters • 02/12/26
Why Vertex Pharmaceuticals (VRTX) is a Top Momentum Stock for the Long-TermZacks Investment Research • 02/12/26
Seeking Clues to Vertex (VRTX) Q4 Earnings? A Peek Into Wall Street Projections for Key MetricsZacks Investment Research • 02/09/26
WuXi Biologics and Vertex Sign License and Research Service Agreement for T-cell EngagerPRNewsWire • 02/03/26
Wall Street Analysts Think Vertex (VRTX) Is a Good Investment: Is It?Zacks Investment Research • 01/23/26
Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12thBusiness Wire • 01/20/26